Cargando…
Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer
Lynch syndrome (LS) is a hereditary cancer syndrome responsible for 3% of all endometrial cancer and 5% in those aged under 70 years. It is unclear whether universal testing for LS in endometrial cancer patients would be cost-effective. The Manchester approach to identifying LS in endometrial cancer...
Autores principales: | Snowsill, Tristan M., Ryan, Neil A. J., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356917/ https://www.ncbi.nlm.nih.gov/pubmed/32492863 http://dx.doi.org/10.3390/jcm9061664 |
Ejemplares similares
-
Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting
por: Snowsill, Tristan M., et al.
Publicado: (2019) -
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
por: Crosbie, Emma J., et al.
Publicado: (2019) -
Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial Cancer
por: Ryan, Neil A. J., et al.
Publicado: (2020) -
The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol
por: Ryan, Neil A. J., et al.
Publicado: (2018) -
The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study
por: Ryan, Neil A. J., et al.
Publicado: (2020)